Skip to content
← Back to this collection

PUBLICATIONS · 19018090

Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: results of the prospective multicenter H96 trial by the GELA/SFGM study group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2008 Dec 20
First author
Morschhauser F

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Morschhauser F
      type
      Author
    2. name
      Brice P
      type
      Author
    3. name
      Fermé C
      type
      Author
    4. name
      Diviné M
      type
      Author
    5. name
      Salles G
      type
      Author
    6. name
      Bouabdallah R
      type
      Author
    7. name
      Sebban C
      type
      Author
    8. name
      Voillat L
      type
      Author
    9. name
      Casasnovas O
      type
      Author
    10. name
      Stamatoullas A
      type
      Author
    11. name
      Bouabdallah K
      type
      Author
    12. name
      André M
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Morschhauser F
      type
      Author
    2. name
      Brice P
      type
      Author
    3. name
      Fermé C
      type
      Author
    4. name
      Diviné M
      type
      Author
    5. name
      Salles G
      type
      Author
    6. name
      Bouabdallah R
      type
      Author
    7. name
      Sebban C
      type
      Author
    8. name
      Voillat L
      type
      Author
    9. name
      Casasnovas O
      type
      Author
    10. name
      Stamatoullas A
      type
      Author
    11. name
      Bouabdallah K
      type
      Author
    12. name
      André M
      type
      Author
    bibliography ids
    1. nci-bib-342937456c7a82f27e173f07
    book metadata
    content sha256
    d248d372cad1275352bf4c60bcda6b02a8ad6323ce9a4c442d39d0a3bfd31608
    document type
    citation
    dois
    1. 10.1200/JCO.2007.15.5887
    electronic publication date
    display
    2008 Nov 17
    precision
    day
    year
    2008
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:19018090
    immutable id
    pubmed:19018090@d248d372cad1275352bf4c60bcda6b02a8ad6323ce9a4c442d39d0a3bfd31608
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    36
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    5980-7
    volume
    26
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      19018090
      provenance
      batch id
      27a383f06e5fc3d04fad
      provider
      NCBI PubMed ESummary
      record sha256
      90f61750c28032825f7799dbef634d8140014a53ef76c089245cd915bc378626
      response sha256
      51f0f2a142dbd9b135e872b049b116f51941299445a5416feae10f12fac8d978
      retrieved at
      2026-09-09T23:46:24.265787+00:00
      publication date
      display
      2008 Dec 20
      precision
      day
      year
      2008
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/19018090/
      title
      Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: results of the prospective multicenter H96 trial by the GELA/SFGM study group.

      Preserved source evidence · Not medical advice